The NHS Genomic Medicine Service supports patients in:
- Making clear and informed choices about genetic and genomic testing
- Understanding the options and implications of their choices
- Making clear and distinct choices about participating in research programmes.
Patients making informed choices
An NHS patient receiving a genomic test can expect to receive guidance and education at every stage of the testing process:
- During their initial referral and consultation
- When they choose to consent to a test
- During any follow-up opportunities to participate in research
- During their ongoing care
The NHS Genomic Medicine Service is pioneering a new approach to medicine that will endure into an exciting new future. Patient feedback and input is highly valued in shaping an exceptional service.
Patient Choice consent framework
A new consent model will soon accompany whole genome sequencing (WGS). In future, the model will also complement the complete National Genomic Test Directories. Under this framework, a record of the discussion about genomic testing should be made when a test is ordered, and all patients undergoing testing will be offered the opportunity to participate in research.
Training and engagement on the Patient Choice framework for consent is in development. Please look for notices on this page or subscribe to our quarterly newsletter for updates.
- 100,000 Genome Project Participant Information Sheets and Consent Forms
- BMC Medical Ethics: Perspectives on consent to clinical genetic testing
- Your questions answered: Confidentiality and ethics